Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
All Registry communications to:
Automic
Group GPO
Box 5193
Sydney NSW 2001
Telephone (free call within Australia): 1300 288 664
ASX/AIM Code: CLA
1 April 2026
Upcoming General Meeting of Shareholders
Dear Shareholder,
Celsius Resources limited ACN 009 162 949 (ASX/AIM: CLA or “the Company”), advises that a General Meeting will be held in
person at Level 5, 191 St Georges Terrace, Perth, Western Australia 6000 on Thursday, 30 April 2026 at 3:00pm AWST (Meeting).
Notice of Meeting
The Notice of Meeting and Explanatory Memorandum (Notice) for the Meeting is available online and can be viewed and
downloaded by shareholders of the Company (Shareholders) from the Company’s website at
https://celsiusresources.com/announcements or the Company's ASX market announcements platform at www.asx.com.au (ASX:
CLA).
In accordance with sections 110C-110K of the Corporations Act 2001 (Cth) (as inserted by the Treasury Laws Amendment (2021
Measures No.1) Act 2021 (Cth), Shareholders will not be sent a hard copy of the Notice or Proxy Form unless Shareholders have
already notified the Company that they wish to receive documents such as the Notice and Proxy Form in hard copy.
Voting by Proxy
For further information on the online proxy lodgment process, or if you require a hard copy Proxy Form, please contact the
Company’s Share Registry, Automic Registry Services (Automic), at hello@automicgroup.com.au or via phone on 1300 288 664
(within Australia) or +61 2 9698 5414 (overseas).
Shareholder queries in relation to the Meeting
Shareholders can contact the Company Secretary with any questions prior to the meeting via email at
info@celsiusresources.com.au.
Copies of all Meeting related material including the Notice, are available to download from the Company’s website and the
Company's ASX market announcements platform. In the event it is necessary or appropriate for the Company to make alternative
arrangements for the Meeting, information will be provided to Shareholders via the ASX and the Company’s website.
Authorised for ASX release by Chairman, Peter Hume.
Online
scan the QR code
below using your
smartphone
Lodge your Proxy vote online at https://investor.automic.com.au/#/loginsah by following the
instructions:
1. Login to the Automic website using the holding details as shown on your holding statement.
2. Click on ‘Meetings’ – ‘Vote’.
To use the online lodgment facility, Shareholders will need their holder number (Securityholder
Reference Number (SRN) or Holder Identification Number (HIN)) as shown at the top of your holding
statement.
Celsius Resources Limited
ACN 009 162 949
Notice of General Meeting
A General Meeting of the Company will be held as follows:
Time and date: 3.00pm (AWST) on Thursday, 30 April 2026
Location: Level 5, 191 St Georges Terrace, Perth WA 6000
The Notice of General Meeting should be read in its entirety. If Shareholders are in doubt as to
how to vote, they should seek advice from their suitably qualified advisor prior to voting.
Should you wish to discuss any matter, please do not hesitate to contact the
Company Secretary by telephone on +61 (8) 9324 4516.
Shareholders are urged to vote by lodging the Proxy Form
Page 2
Celsius Resources Limited
ACN 009 162 949
(Company)
Notice of General Meeting
Notice is hereby given that a general meeting of Shareholders of Celsius Resources Limited (Company) will be
held at Level 5, 191 St Georges Terrace, Perth WA 6000 on Thursday, 30 April 2026 at 3.00pm (AWST)
(Meeting).
The Explanatory Memorandum provides additional information on matters to be considered at the Meeting. The
Explanatory Memorandum and the Proxy Form form part of the Notice.
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that
the persons eligible to vote at the Meeting are those who are registered as Shareholders on Tuesday, 28 April
2026 at 5.00pm (AWST).
Terms and abbreviations used in the Notice are defined in Schedule 1.
Agenda
1 Resolutions
Resolution 1 – Ratification of issue of Tranche 1 Placement Shares
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 463,250,000 Tranche 1 Placement Shares on the terms and conditions in the
Explanatory Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Resolution 2 – Approval to issue Tranche 2 Placement Securities
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders
approve the issue of up to 233,500,000 Tranche 2 Placement Securities on the terms and conditions in
the Explanatory Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Page 3
Resolution 3 – Approval to issue Director Placement Securities
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 10.11 and for all other purposes, Shareholders
approve the issue of up to 500,000 Director Placement Shares and 250,000 Director Placement Options
to Director Neil Grimes (or his nominee/s), on the terms and conditions in the Explanatory
Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Resolution 4 – Approval to issue Broker Options
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, Shareholders
approve the issue of up to 58,125,000 Broker Options, on the terms and conditions in the Explanatory
Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Resolution 5 – Ratification of issue of 2025 AIM Placement Securities
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution the
following:
‘That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes, Shareholders ratify
the issue of 111,300,000 2025 AIM Placement Securities on the terms and conditions in the Explanatory
Memorandum.’
Important Note: The Securities the subject of this Resolution are expressed in this Notice and the
Explanatory Memorandum on a pre-Consolidation basis.
Resolution 6 – Consolidation of capital
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution, the
following:
‘That, pursuant to and in accordance with section 254H of the Corporations Act and for all other
purposes, the issued capital of the Company be consolidated on the terms and conditions in the
Explanatory Memorandum, on the basis that:
(a) every twenty (20) Shares be consolidated into one (1) Share;
(b) every twenty (20) Options be consolidated into one (1) Option; and
(c) every twenty (20) Warrants be consolidated into one (1) Warrant,
Page 4
and where the Consolidation results in a fraction of a Security being held, the Company be authorised
to round that fraction up to the nearest whole Security, on the terms and conditions in the Explanatory
Memorandum.’
2 Voting exclusions
Pursuant to the Listing Rules, the Company will disregard any votes cast in favour of:
(a) Resolution 1: by or on behalf of any person who participated in the issue of the Tranche 1
Placement Shares, or any of their respective associates, or their nominees.
(b) Resolution 2: by or on behalf of Bardin Davis and any other person who is expected to
participate in, or who will obtain a material benefit as a result of, the proposed issue of the
Tranche 2 Placement Securities (except a benefit solely by reason of being a Shareholder), or
any of their respective associates.
(c) Resolution 3: by or on behalf of Neil Grimes (or his nominee/s), and any other person who will
obtain a material benefit as a result of the issue of these Director Placement Securities (except
a benefit solely by reason of being a Shareholder), or any of their respective associates.
(d) Resolution 4: by or on behalf of Evolution Capital Pty Ltd (or its nominee/s), and any other
person who is expected to participate in, or who will obtain a material benefit as a result of, the
proposed issue of the Broker Options (except a benefit solely by reason of being a
Shareholder), or any of their respective associates.
(e) Resolution 5: by or on behalf of any person who participated in the issue of the 2025 AIM
Placement Securities, or any of their respective associates, or their nominees.
The above voting exclusions do not apply to a vote cast in favour of the relevant Resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with directions given to the proxy or attorney to vote on the Resolution in that way;
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides;
or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on the
Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
BY ORDER OF THE BOARD
Peter Hume
Chairman
Celsius Resources Limited
Dated: 31 March 2026
Page 5
Celsius Resources Limited
ACN 009 162 949
(Company)
Explanatory Memorandum
1. Introduction
The Explanatory Memorandum has been prepared for the information of Shareholders in
connection with the business to be conducted at the Meeting to be held at Level 5, 191 St
Georges Terrace, Perth WA 6000 on Thursday, 30 April 2026 at 3.00pm (AWST) (Meeting).
The Explanatory Memorandum forms part of the Notice which should be read in its entirety. The
Explanatory Memorandum contains the terms and conditions on which the Resolutions will be
voted and includes the following information to assist Shareholders in deciding how to vote on
the Resolutions:
Section 2 Action to be taken by Shareholders
Section 3 Resolution 1 – Ratification of issue of Tranche 1 Placement Shares
Section 4 Resolution 2 – Approval to issue Tranche 2 Placement Securities
Section 5 Resolution 3 – Approval to issue Director Placement Securities
Section 6 Resolution 4 – Approval to issue Broker Options
Section 7 Resolution 5 – Ratification of issue of 2025 AIM Placement Securities
Section 8 Resolution 6 – Consolidation of capital
Schedule 1 Definitions
Schedule 2 Terms and conditions of Placement Options and Broker Options
Schedule 3 Terms and conditions of 2025 AIM Placement Broker Warrants
A Proxy Form is made available with the Explanatory Memorandum.
Page 6
2. Action to be taken by Shareholders
Shareholders should read the Notice, including the Explanatory Memorandum, carefully before
deciding how to vote on the Resolutions.
2.1 Voting by proxy
A Proxy Form is made available with this Notice. This is to be used by Shareholders if they wish
to appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited and
encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the
Proxy Form to the Company in accordance with the instructions thereon. Lodgement of a Proxy
Form will not preclude a Shareholder from attending and voting at the Meeting in person.
Please note that:
(a) a member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy;
(b) a proxy need not be a member of the Company; and
(c) a member of the Company entitled to cast two or more votes may appoint two proxies
and may specify the proportion or number of votes each proxy is appointed to exercise,
but where the proportion or number is not specified, each proxy may exercise half of
the votes.
The Proxy Form provides further details on appointing proxies and lodging Proxy Forms.
Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify
the way the proxy is to vote on a particular resolution and, if it does:
(a) the proxy need not vote on a show of hands, but if the proxy does so, the proxy must
vote that way (i.e. as directed);
(b) if the proxy has 2 or more appointments that specify different ways to vote on the
resolution – the proxy must not vote on a show of hands;
(c) if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
must vote on a poll, and must vote that way (i.e. as directed); and
(d) if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does
so, the proxy must vote that way (i.e. as directed).
Section 250BC of the Corporations Act provides that, if:
(a) an appointment of a proxy specifies the way the proxy is to vote on a particular resolution
at a meeting of the Company's members;
(b) the appointed proxy is not the chair of the meeting;
(c) at the meeting, a poll is duly demanded, or is otherwise required under section 250JA
on the resolution; and
(d) either the proxy is not recorded as attending the meeting or the proxy does not vote on
the resolution,
Page 7
the Chair of the meeting is taken, before voting on the resolution closes, to have been appointed
as the proxy for the purposes of voting on the resolution at the meeting.
Your proxy voting instruction must be received by 3.00pm (AWST) on Tuesday, 28 April 2026,
being not later than 48 hours before the commencement of the Meeting.
2.2 Chair's voting intentions
The Chair intends to exercise all available proxies in favour of all Resolutions, unless the
Shareholder has expressly indicated a different voting intention.
2.3 Depositary Interest holders
Persons entitled to vote
The Form of Instruction (accompanying this Notice of Meeting) must be signed by the depositary
interest holder or an attorney duly authorised in writing and deposited at the office of the
Depositary, Computershare Investor Services PLC, located at The Pavilions, Bridgewater Road,
Page 8 Bristol BS99 6ZY by 3.00pm (UK Time) on Friday, 24 April 2026. Any Form of Instruction
received after that time will not be valid for the Meeting.
CREST Voting
Holders of Depositary Interests in CREST may transmit voting instructions by utilising the
CREST voting service in accordance with the procedures described in the CREST Manual.
CREST personal members or other CREST sponsored members, and those CREST members
who have appointed a voting service provider, should refer to their CREST sponsor or voting
service provider, who will be able to take appropriate action on their behalf.
In order for instructions made using the CREST voting service to be valid, the appropriate
CREST message (a “CREST Voting Instruction”) must be properly authenticated in accordance
with Euroclear’s specifications and must contain the information required for such instructions,
as described in the CREST Manual (available via www.euroclear.com).
To be effective, the CREST Voting Instruction must be transmitted so as to be received by the
Company’s agent (3RA50) no later than 3.00pm (UK Time) on Friday, 24 April 2026. For this
purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied
to the CREST Voting Instruction by the CREST applications host) from which the Company’s
agent is able to retrieve the CREST Voting Instruction by enquiry to CREST in the manner
prescribed by CREST.
Holders of Depositary Interests in CREST and, where applicable, their CREST sponsors or
voting service providers should note that Euroclear does not make available special procedures
in CREST for any particular messages. Normal system timings and limitations will therefore
apply in relation to the transmission of CREST Voting Instructions. It is the responsibility of the
Depositary Interest holder concerned to take (or, if the Depositary Interest holder is a CREST
personal member or sponsored member or has appointed a voting service provider, to procure
that the CREST sponsor or voting service provider takes) such action as shall be necessary to
ensure that a CREST Voting Instruction is transmitted by means of the CREST voting service
by any particular time. In this connection, Depositary Interest holders and, where applicable,
their CREST sponsors or voting service providers are referred, in particular, to those sections
of the CREST Manual concerning practical limitations of the CREST system and timings.
Page 8
3. Resolution 1 – Ratification of issue of Tranche 1 Placement Shares
3.1 Background
On 23 February 2026, the Company announced that it had received firm commitments for a
$9.3 million (before costs) placement via the issue of up to 465,000,000 Shares (Placement
Shares) at an issue price of $0.02 per Placement Share (Placement), with one free attaching
option for every two Placement Shares subscribed for and issued in the Placement, expiring 3
years from the date of issue with an exercise price of $0.035 per option (Placement Options).
Evolution Capital Pty Ltd (Lead Manager) acted as the sole lead manager and sole bookrunner
to the Placement. A summary of the Lead Manager Mandate is set out in Section 6.2.
The Placement is comprised of the following tranches:
(a) Tranche 1: the issue of 463,250,000 Placement Shares to unrelated Placement
participants (Tranche 1 Placement Shares), which were issued on 27 February 2026
without prior Shareholder approval under Listing Rule 7.1 (the subject of Resolution 1).
(b) Tranche 2: subject to and conditional on the prior receipt of Shareholder approval, the
issue of:
(i) up to 1,250,000 Placement Shares to unrelated Placement participants
(Tranche 2 Placement Shares); and
(ii) up to 232,250,000 Placement Options to unrelated Placement participants
(Placement Options),
(the subject of Resolution 2).
(c) Tranche 3: subject to and conditional on the prior receipt of Shareholder approval, the
issue of up to 500,000 Placement Shares (Director Placement Shares) and up to
250,000 Placement Options to Neil Grimes (or his nominee/s) (Director Placement
Options) (the subject of Resolution 3).
In addition, the Company has agreed to issue up to 58,125,000 Options to the Lead Manager
(or its nominee/s) as partial consideration for the provision of lead managerial and bookrunner
services in connection with the Placement (Broker Options) (the subject of Resolution 4).
Resolution 1 seeks the approval of Shareholders pursuant to Listing Rule 7.4 to ratify the prior
issue of the Tranche 1 Placement Shares.
The Company confirms that Listing Rule 7.1 was not breached at the time the Tranche 1
Placement Shares were agreed to be issued.
3.2 Listing Rules 7.1 and 7.4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of
Equity Securities that a listed company can issue without the approval of its shareholders over
any 12-month period to 15% of the fully paid ordinary shares it had on issue at the start of that
period.
Listing Rule 7.4 provides an exception to Listing Rules 7.1. It provides that where a company in
a general meeting ratifies the previous issue of securities made pursuant to Listing Rule 7.1
(and provided that the previous issue did not breach Listing Rule 7.1), those securities will be
deemed to have been made with shareholder approval for the purposes of Listing Rule 7.1.
Page 9
The effect of Shareholders passing Resolution 1 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 1 is passed, 463,250,000 Tranche 1 Placement Shares will be excluded in
calculating the Company’s 15% limit in Listing Rule 7.1, effectively increasing the number of
Equity Securities it can issue without Shareholder approval over the 12-month period following
the issue date.
If Resolution 1 is not passed, 463,250,000 Tranche 1 Placement Shares will continue to be
included in the Company’s 15% limit under Listing Rule 7.1, effectively decreasing the number
of Equity Securities the Company can issue or agree to issue without obtaining prior
Shareholder approval, to the extent of 463,250,000 Equity Securities for the 12-month period
following the issue of those Tranche 1 Placement Shares.
3.3 Specific information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in
relation to the ratification of the issue of the Tranche 1 Placement Shares:
(a) The Tranche 1 Placement Shares were issued to professional and sophisticated
investors, none of whom are a related party of the Company or a Material Investor. The
Placement participants were identified through a bookbuild process, which involved the
Company and the Lead Manager seeking expressions of interest to participate in the
Placement from new and existing contacts of the Company and Lead Manager.
(b) A total of 463,250,000 Tranche 1 Placement Shares were issued under Listing Rule 7.1.
(c) The Tranche 1 Placement Shares are fully paid and rank equally in all respects with the
Company’s existing Shares on issue.
(d) The Tranche 1 Placement Shares were issued on 27 February 2026 at an issue price
of $0.02 each.
(e) A summary of the intended use of funds raised from the Placement is set out below:
(i) corporate working capital purposes throughout 2026 including funds being
available to contribute to fees payable to advisors and consultants to support
the process of financing the Maalinao-Caigutan Biyog (MCB) Project in the
Philippines;
(ii) compliance activities for the MCB, Sagay and Botilao projects in the
Philippines as required to maintain these projects and related permits in good
standing whilst the MCB financing is delivered;
(iii) pursuing mineralised extensions at the Botilao Copper-Gold project following
the recent renewal of the exploration permit; and
(iv) fees associated with the Placement.
(f) There are no other material terms to the agreement for the subscription of the Tranche
1 Placement Shares.
(g) A voting exclusion statement is included in the Notice.
Page 10
3.4 Additional information
Resolution 1 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 1.
4. Resolution 2 – Approval to issue Tranche 2 Placement Securities
4.1 General
The background to Placement, including the proposed issue of the Tranche 2 Placement Shares
and Placement Options (together, the Tranche 2 Placement Securities) are set out in Section
3.1 above.
Resolution 2 seeks the approval of Shareholders pursuant to Listing Rule 7.1 to approve the
issue of up to 233,500,000 Tranche 2 Placement Securities in the proportions below:
(a) up to 1,250,000 Tranche 2 Placement Shares; and
(b) up to 232,250,000 Placement Options.
4.2 Listing Rule 7.1
A summary of Listing Rule 7.1 is set out in Section 3.2 above.
The effect of Shareholders passing Resolution 2 will be to allow the Company to retain the
flexibility to issue Equity Securities in the future up to the 15% placement capacity set out in
Listing Rule 7.1, without the requirement to obtain prior Shareholder approval.
If Resolution 2 is passed, the Company will be able to proceed with the issue of the Tranche 2
Placement Securities. In addition, the issue of the Tranche 2 Placement Securities will be
excluded from the calculation of the number of Equity Securities that the Company can issue
without Shareholder approval under Listing Rule 7.1.
If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the
Tranche 2 Placement Securities.
4.3 Specific information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in
relation to the proposed issue of the Tranche 2 Placement Securities:
(a) The Tranche 2 Placement Shares will be issued to Bardin Davis a consultant to the
Company. The Placement Options will be issued to professional and sophisticated
investors who subscribed for and were issued Tranche 1 Placement Shares and Bardin
Davis, none of whom are a related party of the Company or a Material Investor. The
Placement participants were identified through a bookbuild process, which involved the
Company and the Lead Manager seeking expressions of interest to participate in the
Placement from new and existing contacts of the Company and Lead Manager.
(b) A maximum of 233,500,000 Tranche 2 Placement Securities will be issued, in the
proportions below:
(i) up to 1,250,000 Tranche 2 Placement Shares; and
(ii) up to 232,250,000 Placement Options.
Page 11
(c) The Tranche 2 Placement Shares will be fully paid ordinary shares in the capital of the
Company and rank equally in all respects with the Company’s existing Shares on
issue. The Placement Options will be exercisable at $0.035 each and expire 3 years
from the date of issue and will otherwise be on the terms and conditions in Schedule
2.
(d) The Tranche 2 Placement Securities will be issued no later than 3 months after the
date of the Meeting.
(e) The Tranche 2 Placement Shares will be issued at an issue price of $0.02 each, being
the same price at which the Tranche 1 Placement Shares were issued. As the
Placement Options are free attaching to the Placement Shares, the Company will not
receive any cash consideration for the issue of the Placement Options.
(f) Refer to Section 3.3(e) for a summary of the intended use of funds raised from the
Placement.
(g) There are no other material terms to the proposed issue of the Tranche 2 Placement
Securities.
(h) A voting exclusion statement is included in the Notice.
4.4 Additional information
Resolution 2 is an ordinary resolution.
The Board recommends that Shareholders vote in favour of Resolution 2.
5. Resolution 3 – Approval to issue Director Placement Securities
5.1 General
The background to the Placement, including the proposed issue of Director Placement Shares
and Director Placement Options (together, the Director Placement Securities) is set out in
Section 3.1 above.
Director Neil Grimes wishes to participate in the Placement on the same terms as other
unrelated investors of up to $10,000, being the issue of up to 500,000 Director Placement
Shares and 250,000 Director Placement Options.
Resolution 3 seeks the approval of Shareholders pursuant to Listing Rule 10.11 for the issue of
the Director Placement Securities to Mr Grimes (or his nominee/s).
5.2 Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company must not issue or agree to issue Equity Securities to any of the following persons
without the approval of Shareholders:
(a) a related party (Listing Rule 10.11.1);
(b) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (30%+) in the company (Listing Rule 10.11.2);
(c) a person who is, or was at any time in the 6 months before the issue or agreement, a
substantial holder (10%+) in the company and who has nominated a director to the
Page 12
board of the company pursuant to a relevant agreement which gives them a right or
expectation to do so (Listing Rule 10.11.3);
(d) an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3 (Listing
Rule 10.11.4); or
(e) a person whose relationship with the company or a person referred to in Listing
Rules 10.11.1 or 10.11.4 is such that, in ASX’s opinion, the issue or agreement should
be approved by its shareholders (Listing Rule 10.11.5).
Mr Grimes is a related party of the Company by virtue of being a director of the Company.
Shareholder approval pursuant to Listing Rule 10.11 is therefore required unless an exception
applies. It is the view of the Board (with Mr Grimes abstaining) that the exceptions set out in
Listing Rule 10.12 do not apply in the current circumstances.
Approval pursuant to Listing Rule 7.1 is not required for the issue of the Director Placement
Securities as approval is being obtained under Listing Rule 10.11. Accordingly, the issue of
these Director Placement Securities to Mr Grimes (or his nominee/s) will not be included in the
Company’s 15% placement capacity pursuant to Listing Rule 7.1.
The effect of Shareholders passing Resolution 3 will be to allow the Company to issue the
Director Placement Securities, raising $10,000 (before costs) under the Placement.
If Resolution 3 is not passed, the Company will not be able to proceed with the issue of the
Director Placement Securities and will not raise the additional $10,000 (before costs) committed
by Mr Grimes.
5.3 Specific information required by Listing Rule 10.13
Pursuant to and in accordance with Listing Rule 10.13, the following information is provided in
relation to the proposed issue of the Director Placement Securities:
(a) The Director Placement Securities will be issued to Mr Grimes (or his nominee/s) as
follows:
(i) up to 500,000 Director Placement Shares; and
(ii) up to 250,000 Director Placement Options.
(b) Mr Grimes falls into the category stipulated by Listing Rule 10.11.1. In the event the
Director Placement Securities are issued to his nominee, that nominee will fall into the
category stipulated by Listing Rule 10.11.4.
(c) A maximum of 500,000 Dir
Share your feedback
Discover